These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose. Teligui L, Dalmayrac E, Mabilleau G, Macchi L, Godon A, Corbeau JJ, Denommé AS, Bouquet E, Boer C, Baufreton C. Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424 [Abstract] [Full Text] [Related]
6. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M. Circulation; 1995 Nov 01; 92(9):2579-84. PubMed ID: 7586360 [Abstract] [Full Text] [Related]
7. Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces. Palatianos GM, Dewanjee MK, Smith W, Novak S, Hsu LC, Kapadvanjwala M, Sfakianakis GN, Kaiser GA. ASAIO Trans; 1991 Nov 01; 37(4):620-2. PubMed ID: 1722689 [Abstract] [Full Text] [Related]
8. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study. Borowiec J, Thelin S, Bagge L, van der Linden J, Thörnö E, Hansson HE. Ups J Med Sci; 1992 Nov 01; 97(1):55-66. PubMed ID: 1523735 [Abstract] [Full Text] [Related]
15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA, Aeba R, Yousem SA, Griffith BP, Marrone GC. J Heart Lung Transplant; 1994 Jan 01; 13(3):498-507. PubMed ID: 8061027 [Abstract] [Full Text] [Related]
16. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility. Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W. Ann Thorac Surg; 1998 May 01; 65(5):1342-7. PubMed ID: 9594864 [Abstract] [Full Text] [Related]
17. Effect of polymer coating (poly 2-methoxyethylacrylate) of the oxygenator on hemostatic markers during cardiopulmonary bypass in children. Eisses MJ, Geiduschek JM, Jonmarker C, Cohen GA, Chandler WL. J Cardiothorac Vasc Anesth; 2007 Feb 01; 21(1):28-34. PubMed ID: 17289476 [Abstract] [Full Text] [Related]
18. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management. Weiss BM, von Segesser LK, Turina MI, Seifert B, Pasch T. J Cardiothorac Vasc Anesth; 1996 Jun 01; 10(4):464-70. PubMed ID: 8776638 [Abstract] [Full Text] [Related]
19. Protective effect of heparin-coated circuits on the platelets during cardiopulmonary bypass. Zhang K, Hu Z, Yang Y, Huang R, Fan H, Sun Z. J Huazhong Univ Sci Technolog Med Sci; 2003 Jun 01; 23(4):403-6. PubMed ID: 15015647 [Abstract] [Full Text] [Related]
20. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. Borowiec JW, Bylock A, van der Linden J, Thelin S. Ann Thorac Surg; 1993 Jun 01; 55(6):1540-5. PubMed ID: 8512409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]